A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
29th Annual San Antonio Breast Cancer Symposium - Summary Coverage
Date: December 14-17, 2006
Location: San Antonio, Texas

The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the 29th Annual San Antonio Breast Cancer Symposium.
29th Annual San Antonio Breast Cancer Symposium Conference Summaries
Date: December 14-17, 2006
Location: San Antonio, Texas
Author:
Advances in Supportive Care
Lee Schwartzberg, MD, FACP, The West Clinic 

Developments in the Treatment of Metastatic Breast Cancer
Lee Schwartzberg, MD, FACP, The West Clinic 

Developments in Adjuvant and Neoadjuvant Treatment of Breast Cancer
Lee Schwartzberg, MD, FACP, The West Clinic 

29th Annual San Antonio Breast Cancer Symposium News Stories
Follow-Up Data on Dose-Dense Chemotherapy Confirms Benefit in Early Breast Cancer (1/10/2007)

Oncotype DX™ Accurately Measures Estrogen Receptor Status in Node-Negative Breast Cancer Patients (1/9/2007)

Follow-Up Data Indicate Low-Fat Diet May Significantly Reduce Recurrences in ER-Negative Breast Cancer (1/8/2007)

Addition of Tykerb® Improves Progression-Free Survival in Advanced Breast Cancer (1/5/2007)

Boost Radiation for Early Breast Cancer Improves Local Control, Not Survival (1/4/2007)

Abraxane in Combination with Xeloda Effective Against Metastatic Breast Cancer (1/3/2007)

Re-Induction Chemotherapy May Improve Survival for Some Patients with Stage IIIB Breast Cancer (1/2/2007)

Aromasin® and Faslodex® Similarly Effective and Safe As Second-Line or Greater Endrocrine Therapy in Breast Cancer (1/2/2007)

Surgery Alone May Be Not Effective Enough in High-Grade DCIS (12/20/2006)

Tykerb® Effective in Inflammatory Breast Cancer (12/20/2006)

Compared to Taxotere®, Abraxane® Improves Response Rates and Progression-Free Survival With Fewer Side Effects (12/19/2006)

Reduction in Hormone Replacement Therapy Linked to Drop in Breast Cancer Cases (12/19/2006)

Herceptin® Continues to Demonstrate Improved Survival in Early Breast Cancer (12/18/2006)

HER2 Vaccine May Help Reduce Recurrences in Breast Cancer (12/14/2006)

Combination of Herceptin®/Arimidex® Prolongs Progression-Free Survival in HER2-Positive, Hormone-Dependent Advanced Breast Cancer (12/14/2006)
2007 Conferences
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.